02360nam 2200565 450 991081425700332120230803024235.01-78084-309-7(CKB)2560000000152104(EBL)1179627(SSID)ssj0001599919(PQKBManifestationID)16306842(PQKBTitleCode)TC0001599919(PQKBWorkID)14892848(PQKB)11518884(MiAaPQ)EBC1179627(Au-PeEL)EBL1179627(OCoLC)876507114(EXLCZ)99256000000015210420220517d2013 uy 0engur|n|---|||||txtccrAdvances in the management of pulmonary arterial hypertension /editors, Kimberly A. Smith, Dustin R. Fraidenburg, Jason X.-J. Yuan1st ed.London, England :Future Medicine Ltd.,[2013]©20131 online resource (129 p.)Description based upon print version of record.1-78084-311-9 Title page; Copyright page; Contents; Foreword. Current therapies for the treatment of pulmonary arterial hypertension; 1. Etiology and prevalence of pulmonary arterial hypertension; 2. Pathology and diagnosis of pulmonary arterial hypertension; 3. Conventional therapy; 4. Targeted therapies: prostaglandins; 5. Targeted therapies: endothelin receptor antagonists ; 6. Stimulators and activators of soluble guanylate cyclase: potential therapeutic indications; 7. Surgical approaches in pulmonary arterial hypertension; 8. Monitoring and prognosis of pulmonary arterial hypertension9. Right ventricular failureIndexAdvances in the Management of Pulmonary Arterial HypertensionPulmonary hypertensionPulmonary hypertensionTreatmentPulmonary hypertension.Pulmonary hypertensionTreatment.616.24Yuan Jason X.-J.1963-Fraidenburg Dustin R.Smith Kimberly A.MiAaPQMiAaPQMiAaPQBOOK9910814257003321Advances in the management of pulmonary arterial hypertension4112040UNINA